Drug Shortage Report for EMLA CREAM
| Report ID | 222665 |
| Drug Identification Number | 00886858 |
| Brand name | EMLA CREAM |
| Common or Proper name | lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | LIDOCAINE PRILOCAINE |
| Strength(s) | 2.5% 2.5% |
| Dosage form(s) | CREAM |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 1 Tube |
| ATC code | D04AB |
| ATC description | ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC. |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-05-01 |
| Actual start date | |
| Estimated end date | 2024-06-30 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2024-03-18 |
| Company comments | CAD2EM012B1 EMLA 50MG/G CRM 5G TUB CA ASP |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-03-18 | French | Compare |
| v1 | 2024-03-18 | English | Compare |
Showing 1 to 2 of 2